Cargando…

Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain

INTRODUCTION: The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer’s disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess whether society can afford it. The objective of this study was to carry out a budget impac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mar, Javier, Ibarrondo, Oliver, Larrañaga, Igor, Mar-Barrutia, Lorea, Soto-Gordoa, Myriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652901/ https://www.ncbi.nlm.nih.gov/pubmed/36371267 http://dx.doi.org/10.1186/s13195-022-01111-7

Ejemplares similares

Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease
por: Mar, Javier, et al.
Publicado: (2020)

Excess healthcare costs of mental disorders in children, adolescents and young adults in the Basque population registry adjusted for socioeconomic status and sex
por: Larrañaga, Igor, et al.
Publicado: (2023)

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
por: Mar, Javier, et al.
Publicado: (2019)

Effect Size Analyses of Souvenaid in Patients with Alzheimer’s Disease
por: Cummings, Jeffrey, et al.
Publicado: (2016)

Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease
por: Scheltens, Nienke M.E., et al.
Publicado: (2019)

Development and Validation of a Discrete Event Simulation Model to Evaluate the Cardiovascular Impact of Population Policies for Obesity
por: Arrospide, Arantzazu, et al.
Publicado: (2021)

Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model
por: Arrospide, Arantzazu, et al.
Publicado: (2018)

Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis
por: Arrospide, Arantzazu, et al.
Publicado: (2016)

Efficacy of Souvenaid(®) Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease
por: García-Alberca, José María, et al.
Publicado: (2023)

Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia
por: Mar, Javier, et al.
Publicado: (2015)

Impacto de la identificación de pacientes en un programa de cuidados paliativos del País Vasco
por: Larrañaga, Igor, et al.
Publicado: (2019)

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease
por: Shah, Raj C, et al.
Publicado: (2013)

Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
por: Rijpma, Anne, et al.
Publicado: (2015)

Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease
por: Scheltens, Nienke M.E., et al.
Publicado: (2016)

The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study
por: de Waal, Hanneke, et al.
Publicado: (2014)

Modeling the initial phase of COVID-19 epidemic: The role of age and disease severity in the Basque Country, Spain
por: Srivasrav, Akhil Kumar, et al.
Publicado: (2022)

Souvenaid in the management of mild cognitive impairment: an expert consensus opinion
por: Cummings, Jeffrey, et al.
Publicado: (2019)

The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer’s disease: results from a randomized controlled trial
por: Rijpma, Anne, et al.
Publicado: (2017)

Changes in Social and Clinical Determinants of COVID-19 Outcomes Achieved by the Vaccination Program: A Nationwide Cohort Study
por: Ibarrondo, Oliver, et al.
Publicado: (2022)

Inflammaging as a prodrome to Alzheimer's disease
por: Giunta, Brian, et al.
Publicado: (2008)

Amyloid imaging in prodromal Alzheimer's disease
por: Ossenkoppele, Rik, et al.
Publicado: (2011)

Observational Study Evaluating the Economic Impact of Breakthrough Pain in Cancer Patients in Clinical Practice in Spain: The IMDI Study
por: Pérez-Hernández, Concepción, et al.
Publicado: (2018)

Assessment of a Potential Synergistic Effect of Souvenaid(®) in Mild Alzheimer’s Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study
por: Viñuela, Félix, et al.
Publicado: (2021)

Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
por: Calleja, Miguel Angel, et al.
Publicado: (2023)

Validation of Random Forest Machine Learning Models to Predict Dementia-Related Neuropsychiatric Symptoms in Real-World Data
por: Mar, Javier, et al.
Publicado: (2020)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

Brainstem substructures and cognition in prodromal Alzheimer’s disease
por: Dutt, Shubir, et al.
Publicado: (2021)

Deep brain stimulation for obsessive-compulsive disorder: A systematic review of worldwide experience after 20 years
por: Mar-Barrutia, Lorea, et al.
Publicado: (2021)

Involvement of mirror neuron system in prodromal Alzheimer's disease
por: Moretti, D.V.
Publicado: (2016)

Targeting prodromal Alzheimer’s disease: too late for prevention?
por: Yassine, Hussein N
Publicado: (2017)

Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s disease
por: Nakamura, Akinori, et al.
Publicado: (2018)

Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease
por: Nielsen, Rune B., et al.
Publicado: (2020)

A Case of Minimally Progressive Prodromal Alzheimer’s Disease
por: Rosenbloom, Michael H., et al.
Publicado: (2023)

Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease
por: Guieysse, Thomas, et al.
Publicado: (2023)

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023)

Prodromal Alzheimer’s Disease: Constitutive Upregulation of Neuroglobin Prevents the Initiation of Alzheimer’s Pathology
por: de Vidania, Silvia, et al.
Publicado: (2020)

Hospitalization budget impact during the COVID-19 pandemic in Spain
por: Carrera-Hueso, F. J., et al.
Publicado: (2021)

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia
por: Hackett, Katherine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t7j1c6ddddau1tufam2416hbes